{"DataElement":{"publicId":"4420736","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy AJCC Edition 7 Clinical N Stage","preferredDefinition":"Stage related to post-neoadjuvant therapy clinical N stage for a breast tumor, the extent of lymph node involvement of a malignant neoplasm of the breast based on clinical observation using the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.","longName":"2663809v1.0:4420724v1.0","context":"BOLD","contextVersion":"1","DataElementConcept":{"publicId":"2663809","version":"1","preferredName":"Breast Tumor Post Neoadjuvant Therapy Clinical N Stage","preferredDefinition":"information related to post-neoadjuvant therapy clinical N stage for a breast tumor, the extent of lymph node involvement of a malignant neoplasm of the breast based on clinical observation using the TMN staging system following treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"BRST_TUM_P_NEOAD_C_N","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206465","version":"1","preferredName":"Breast Neoplasm","preferredDefinition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C12971:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast","conceptCode":"C12971","definition":"One of two hemispheric projections of variable size situated in the subcutaneous layer over the pectoralis major muscle on either side of the chest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0428-F64A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2663807","version":"1","preferredName":"Post Neoadjuvant Therapy Clinical N Stage","preferredDefinition":"Post; occuring after.:Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.:Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C38008:C15665:C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Post","conceptCode":"C38008","definition":"Happening at a time subsequent to a reference time; later in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FDF722-4D36-463A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"ONEDATA","dateModified":"2007-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"34FDF722-4D47-463A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-07-11","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-07-11","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4420724","version":"1","preferredName":"Breast Cancer Neoadjuvant American Joint Committee on Cancer (AJCC) Edition 7 Clinical N Stage","preferredDefinition":"A clinical finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"4420724v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"4","maxLength":"4","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"ycN0","valueDescription":"Breast Cancer Neoadjuvant cN0 TNM Finding","ValueMeaning":{"publicId":"4420726","version":"1","preferredName":"Breast Cancer Neoadjuvant cN0 TNM Finding","longName":"4420726","preferredDefinition":"Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy. : Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Cancer cN0 TNM Finding v6 and v7","conceptCode":"C73347","definition":"Breast cancer with no regional lymph node metastasis. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF8457C0-9BDB-A87E-E040-BB89AD43333B","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF8457C0-9BF4-A87E-E040-BB89AD43333B","beginDate":"2012-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"ycN1","valueDescription":"Breast Cancer Neoadjuvant cN1 TNM Finding","ValueMeaning":{"publicId":"4420727","version":"1","preferredName":"Breast Cancer Neoadjuvant cN1 TNM Finding","longName":"4420727","preferredDefinition":"Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy. : Breast cancer with metastasis to movable ipsilateral level I, II axillary lymph node(s).  (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Cancer cN1 TNM Finding v6 and v7","conceptCode":"C73348","definition":"Breast cancer with metastasis to movable ipsilateral level I, II axillary lymph node(s).  (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF8457C0-9C01-A87E-E040-BB89AD43333B","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF8457C0-9C1A-A87E-E040-BB89AD43333B","beginDate":"2012-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"ycN2","valueDescription":"Breast Cancer Neoadjuvant cN2 TNM Finding v7","ValueMeaning":{"publicId":"4420728","version":"1","preferredName":"Breast Cancer Neoadjuvant cN2 TNM Finding v7","longName":"4420728","preferredDefinition":"Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy. : Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Cancer cN2 TNM Finding v7","conceptCode":"C88368","definition":"Breast cancer with metastases in ipsilateral level I, II axillary lymph nodes that are clinically fixed or matted; or in clinically detected ipsilateral internal mammary nodes in the absence of clinically evident axillary lymph node metastases.  \"Clinically detected\" is defined as detected by imaging studies (excluding lymphoscintigraphy) or by clinical examination and having characteristics highly suspicious for malignancy or a presumed pathologic macrometastasis based on fine needle aspiration biopsy with cytologic examination. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF8457C0-9C27-A87E-E040-BB89AD43333B","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF8457C0-9C40-A87E-E040-BB89AD43333B","beginDate":"2012-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"ycN3","valueDescription":"Breast Cancer Neoadjuvant cN3 TNM Finding v7","ValueMeaning":{"publicId":"4420729","version":"1","preferredName":"Breast Cancer Neoadjuvant cN3 TNM Finding v7","longName":"4420729","preferredDefinition":"Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy. : Breast cancer with metastases in ipsilateral infraclavicular (level III) axillary lymph node(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Cancer cN3 TNM Finding v7","conceptCode":"C88370","definition":"Breast cancer with metastases in ipsilateral infraclavicular (level III) axillary lymph node(s) with or without level I, II axillary lymph node involvement; or in clinically detected ipsilateral internal mammary lymph node(s) with clinically evident level I, II axillary lymph node metastases; or metastases in ipsilateral supraclavicular lymph node(s) with or without axillary or internal mammary lymph node involvement. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF8457C0-9C4D-A87E-E040-BB89AD43333B","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF8457C0-9C66-A87E-E040-BB89AD43333B","beginDate":"2012-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"},{"value":"ycNX","valueDescription":"Breast Cancer Neoadjuvant cNX TNM Finding","ValueMeaning":{"publicId":"4420730","version":"1","preferredName":"Breast Cancer Neoadjuvant cNX TNM Finding","longName":"4420730","preferredDefinition":"Treatment given as a first step to shrink a tumor before the main treatment, which is usually surgery, is given. Examples of neoadjuvant therapy include chemotherapy, radiation therapy, and hormone therapy. It is a type of induction therapy. : Breast cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Breast Cancer cNX TNM Finding v6 and v7","conceptCode":"C73346","definition":"Breast cancer in which regional lymph nodes cannot be assessed. (from AJCC 6th and 7th Eds.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF8457C0-9C73-A87E-E040-BB89AD43333B","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF8457C0-9C8C-A87E-E040-BB89AD43333B","beginDate":"2012-03-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"ONEDATA","dateModified":"2014-07-31","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3655843","version":"1","preferredName":"Breast Cancer Clinical Regional Lymph Nodes TNM Finding v7 American Joint Committee on Cancer Stage","preferredDefinition":"A clinical finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C88366:C39315:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Breast Cancer Clinical Regional Lymph Nodes TNM Finding v7","conceptCode":"C88366","definition":"A clinical finding about one or more characteristics of breast cancer, following the rules of the TNM AJCC v7 classification system as they pertain to staging of regional lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D41053E9-A5A2-7FA6-E040-BB89AD436299","latestVersionIndicator":"Yes","beginDate":"2013-01-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-01-24","modifiedBy":"ONEDATA","dateModified":"2013-01-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF8457C0-9BC0-A87E-E040-BB89AD43333B","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"REEVESD","dateModified":"2014-07-31","changeDescription":"Added concept for Clinical N Stage to reflect PVs related to AJCC staging. mc 1/24/13","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3461586","version":"1","longName":"BOLD:Breast Oncology Local Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461587","version":"1","longName":"Preoperative Elements","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Neoadjuvant Clinical N Stage","type":"Preferred Question Text","description":"Neoadjuvant Clinical N Stage","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"FF8457C0-9CE2-A87E-E040-BB89AD43333B","latestVersionIndicator":"Yes","beginDate":"2014-07-31","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-31","modifiedBy":"REEVESD","dateModified":"2016-09-06","changeDescription":"Curated to support BOLD Preoperative CRF.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}